Keloid Scars: A Comprehensive Review of Pathophysiology, Aetiology, and Therapies
Main Article Content
Abstract
This is an integrative review of the literature which analyses the studies of treatments of keloid scars, touching on the pathophysiology and aetiology of the scars. The paper explores all the different aetiology which could lead to keloid scars such as genetics, inflammatory cells and growth factors including Tenasin C, TGF-β1 and β2; all the risk factors which cause the scars; an in-depth detail of all the pathways and protein alteration of the scars such as extracellular matrix proteins and ECM-associated proteins; the epigenetics of keloid scarring including DNA methylation and histone modifications. In addition to this, the paper ended with a detailed analysis of the different treatments for keloid scarring including surgery, radiotherapy, interferons, botulinum toxins and bleomycin. These findings showed that while there are many hypotheses regarding the pathophysiology and aetiology of the keloid scars by understanding the protein alteration and pathways, many scientists have created adequate treatments for it. With the current advancement, the treatments all have their own limitations but this study aims to summarise each limitation to provide pathways to best treat the keloid scars.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Nangole FW, Agak GW. Keloid pathophysiology: fibroblast or inflammatory disorders? JPRAS Open [Internet]. 2019 Dec 1 [cited 2021 Mar 26];22:44–54. Available from:
https://www.sciencedirect.com/science/article/pii/S2352587819300439
II. Robles DT, Moore E, Draznin M, Berg D. Keloids: Pathophysiology and management. Dermatology Online Journal. 2007;13(3).
III. Naik PP. Novel targets and therapies for keloid. Clinical and Experimental Dermatology. 2021 Oct 10;47(3):507–15.
IV. Ogawa R. The Most Current Algorithms for the Treatment and Prevention of Hypertrophic Scars and Keloids: A 2020 Update of the Algorithms Published 10 Years Ago. Plastic and Reconstructive Surgery [Internet]. 2022 Jan 1;149(1):79e. Available from: https://journals.lww.com/plasreconsurg/Fulltext/2022/01000/The_Most_Current_Algorithms_for_the_Treatment_and.39.aspx?WT.mc_id=HPxADx201003
V. Searle T, Ali FR, Al-Niaimi F. The role of pharmacogenetics in keloid scar treatment: A literature review. Scars, Burns & Healing. 2020 Jan;6:205951312094170.
VI. Marneros AG, Norris JE, Watanabe S, Reichenberger E, Olsen BR. Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11. Journal of Investigative Dermatology. 2004 May 1;122(5):1126-32.
VII. Shah SS, Aziz J, Jaffari AR, Waris S, Ejaz W, Fatima M, Sherazi SK. The impact of brands on consumer purchase intentions. Asian Journal of Business Management. 2012 Apr 15;4(2):105-10.
VIII. Ogawa R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. International journal of molecular sciences. 2017 Mar 10;18(3):606.
IX. Nakashima M, Chung S, Takahashi A, Kamatani N, Kawaguchi T, Tsunoda T, Hosono N, Kubo M, Nakamura Y, Zembutsu H. A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population. Nature genetics. 2010 Sep;42(9):768-71.
X. Shih B, Bayat A. Genetics of keloid scarring. Archives of dermatological research. 2010 Jul;302:319-39.
XI. D’Orazio J, Jarrett S, Amaro-Ortiz A, Scott T. UV radiation and the skin. International journal of molecular sciences. 2013 Jun 7;14(6):12222-48.
XII. Liu J, Yang C, Zhang H, Hu W, Bergquist J, Wang H, Deng T, Yang X, Zhang C, Zhu Y, Chi X. Quantitative proteomics approach reveals novel biomarkers and pathological mechanism of keloid. PROTEOMICS–Clinical Applications. 2022 Jul;16(4):2100127.
XIII. Kim S, Lee SE, Yi S, Jun S, Yi YS, Nagar H, Kim CS, Shin C, Yeo MK, Kang YE, Oh SH. Tauroursodeoxycholic acid decreases keloid formation by reducing endoplasmic reticulum stress as implicated in the pathogenesis of keloid. International journal of molecular sciences. 2021 Oct 5;22(19):10765.
XIV. Zhou L, Liu Z, Chen S, Qiu J, Li Q, Wang S, Zhou W, Chen D, Yang G, Guo L. Transcription factor EB mediated autophagy promotes dermal fibroblast differentiation and collagen production by regulating endoplasmic reticulum stress and autophagy dependent secretion. International journal of molecular medicine. 2021 Feb 1;47(2):547-60.
XV. Nadanaka S, Yoshida H, Kano F, Murata M, Mori K. Activation of mammalian unfolded protein response is compatible with the quality control system operating in the endoplasmic reticulum. Molecular biology of the cell. 2004 Jun;15(6):2537-48.
XVI. Butler PD, Wang Z, Ly DP, Longaker MT, Koong AC, Yang GP. Unfolded protein response regulation in keloid cells. Journal of Surgical Research. 2011 May 1;167(1):151-7.
XVII. Yan Z, Zhang W, Xu P, Zheng W, Lin X, Zhou J, Chen J, He QY, Zhong J, Guo J, Cheng B. Phosphoproteome and biological evidence revealed abnormal calcium homeostasis in keloid fibroblasts and induction of aberrant platelet aggregation. Journal of Proteome Research. 2021 Mar 12;20(5):2521-32.
XVIII. Ding F, Yang L, Wang Y, Wang J, Ma Y, Jin J. Serum Rcn3 level is a potential diagnostic biomarker for connective tissue disease-associated interstitial lung disease and reflects the severity of pulmonary function. BMC Pulmonary Medicine. 2023 Dec;23(1):1-0.
XIX. Lv W, Ren Y, Hou K, Hu W, Yi Y, Xiong M, Wu M, Wu Y, Zhang Q. Epigenetic modification mechanisms involved in keloid: current status and prospect. Clinical epigenetics. 2020 Dec;12(1):1-9.
XX. Russell SB, Russell JD, Trupin KM, Gayden AE, Opalenik SR, Nanney LB, Broquist AH, Raju L, Williams SM. Epigenetically altered wound healing in keloid fibroblasts. Journal of investigative dermatology. 2010 Oct 1;130(10):2489-96.
XXI. Lin X, Wang Y, Jiang Y, Xu M, Pang Q, Sun J, Yu Y, Shen Z, Lei R, Xu J. Sumoylation enhances the activity of the TGF-β/SMAD and HIF-1 signaling pathways in keloids. Life Sciences. 2020 Aug 15;255:117859.
XXII. Huang C, Liu L, You Z, Du Y, Ogawa R. Managing keloid scars: From radiation therapy to actual and potential drug deliveries. International wound journal. 2019 Jun;16(3):852-9.
XXIII. He Y, Deng Z, Alghamdi M, Lu L, Fear MW, He L. From genetics to epigenetics: new insights into keloid scarring. Cell proliferation. 2017 Apr;50(2):e12326.
XXIV. Kim JK, Samaranayake M, Pradhan S. Epigenetic mechanisms in mammals. Cellular and molecular life sciences. 2009 Feb;66:596-612.
XXV. Abeer Attia Tawfik, Rama Ahmad Ali. Evaluation of botulinum toxin type A for treating post burn hypertrophic scars and keloid in children: An intra‐patient randomized controlled study. Journal of Cosmetic Dermatology. 2023 Jan 31;22(4).
XXVI. Ogawa R, Tosa M, Dohi T, Akaishi S, Kuribayashi S. Surgical excision and postoperative radiotherapy for keloids. Scars, Burns & Healing [Internet]. 2019 Dec 10 [cited 2021 Apr 28];5. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904783/
XXVII. Zainib M, Amin NP. Radiation Therapy In The Treatment Of Keloids [Internet]. PubMed. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499973/
XXVIII. Fernandes MG, da Silva LP, Cerqueira MT, Ibañez R, Murphy CM, Reis RL, Marques AP. Mechanomodulatory biomaterials prospects in scar prevention and treatment. Acta Biomaterialia. 2022 Jul 29.
XXIX. Yin Q, Niessen FB, Gibbs S, Lapid O, Louter JM, Van Zuijlen PP, Wolkerstorfer A. Intralesional corticosteroid administration in the treatment of keloids: a survey among Dutch dermatologists and plastic surgeons. Journal of Dermatological Treatment. 2023 Dec 31;34(1):2159308.
XXX. Han Y, Sun Y, Yang F, Liu Q, Fei W, Qiu W, Wang J, Li L, Zhang X, Wang A, Cui Y. Non-invasive imaging of pathological scars using a portable handheld two-photon microscope. Chinese Medical Journal. 2023 Jul 31:10-97.
XXXI. Hu Y, Zhou X, Chen L, Li R, Jin S, Liu L, Ju M, Luan C, Chen H, Wang Z, Huang D. Landscape of circulating metabolic fingerprinting for keloid. Frontiers in Immunology. 2022 Sep 29;13:1005366.
XXXII. Kim M, Mirsky N, Spielman A, Mathew P, Yechieli R, Tang JC, Thaller SR. Evaluating Symptomatic and Psychosocial Well-being After Keloid Treatment With SCAR-Q. Aesthetic surgery journal. 2022 Jun 1;42(6):NP416-22.